Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Department of Medical Engineering and Cardiology, Institute of Development Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan.
Heart Vessels. 2022 May;37(5):794-801. doi: 10.1007/s00380-021-01969-x. Epub 2021 Oct 22.
Factors causing atrial tachyarrhythmia recurrence after catheter ablation (CA) of atrial fibrillation (AF) remain undetermined. This study aimed to investigate the effect of nocturnal hypoxemia on the recurrence of atrial tachyarrhythmia after CA of AF. Among 594 patients with AF who underwent an ambulatory sleep study at the National Cerebral and Cardiovascular Center, Suita, Osaka, Japan (2014-2019), 365 underwent CA of AF; 290 patients who underwent CA were followed up for > 3 months. Multivariate Cox regression analysis was used to calculate hazard ratios (HRs) using clinical variables, to identify the independent predictors of atrial tachyarrhythmia recurrence after the final CA. Atrial tachyarrhythmia recurred in 45 of 290 (15.5%) patients during the median follow-up period of 479 days (interquartile range 225-1002). On the performing multivariate analysis of the data of patients who did not receive continuous positive airway pressure (CPAP), severe nocturnal hypoxemia [defined as the percentage of sleep time spent with SaO of < 90% (T90) over 20%] [HR 8.53, 95% confidence interval (CI) 1.872-38.814; P < 0.01] and an 1 mL/m increase in the left atrial volume index (HR 1.02, 95% CI 1.004-1.044; P = 0.02) were found to be independently associated with the recurrence of atrial tachyarrhythmia. In addition, the rates of freedom from atrial tachyarrhythmia after the final AF ablation with CPAP were significantly lower in the group with more severe nocturnal hypoxemia (Log-rank P = 0.03). In conclusion, it is necessary to consider both, AHI and nocturnal hypoxia while performing an ambulatory sleep apnea study. CA may be less effective in patients with more severe nocturnal hypoxia, despite the administration of CPAP.
心房颤动(AF)导管消融(CA)后引起房性心动过速(AT)复发的因素仍不确定。本研究旨在探讨夜间低氧血症对 AF 导管消融后房性心动过速复发的影响。在日本大阪吹田市国立循环器病研究中心进行的 594 例 AF 患者动态睡眠研究中(2014-2019 年),365 例行 AF CA;290 例接受 CA 的患者随访时间超过 3 个月。使用多变量 Cox 回归分析,使用临床变量计算危险比(HR),以确定 CA 后 AT 复发的独立预测因素。在中位随访 479 天(四分位距 225-1002)期间,290 例患者中有 45 例(15.5%)复发 AT。对未接受持续气道正压通气(CPAP)的患者进行多变量分析,发现严重夜间低氧血症[定义为睡眠中 SaO2<90%的时间百分比(T90)超过 20%] [HR 8.53,95%置信区间(CI)1.872-38.814;P<0.01]和左心房容积指数增加 1ml/m[HR 1.02,95%CI 1.004-1.044;P=0.02]与 AT 复发独立相关。此外,CPAP 治疗后,夜间低氧血症更严重的患者,AF 消融后无 AT 复发率明显降低(Log-rank P=0.03)。总之,在进行动态睡眠呼吸暂停研究时,有必要同时考虑 AHI 和夜间缺氧。尽管给予 CPAP,但 CA 在夜间缺氧更严重的患者中可能效果较差。